Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
52.01 USD | -3.49% |
|
+17.51% | +13.44% |
07-08 | Rhythm Pharmaceuticals Appoints Alastair Garfield as Chief Scientific Officer | MT |
07-08 | Rhythm Pharmaceuticals, Inc. Announces Appointment of Alastair Garfield, as Chief Scientific Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.44% | 3.29B | |
+18.19% | 126B | |
+23.26% | 118B | |
+23.26% | 27.87B | |
-18.75% | 20.95B | |
-15.13% | 16.92B | |
-15.01% | 16.18B | |
+9.34% | 14.84B | |
-46.10% | 14.79B | |
+52.26% | 14.08B |
- Stock Market
- Equities
- RYTM Stock
- News Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals, Inc. announced a financing transaction